Bibliographic Details
| Title: |
Second‐generation antipsychotics and VTE risk. |
| Authors: |
DeLoughery, Emma P.1 (AUTHOR) deloughe@ohsu.edu |
| Source: |
European Journal of Haematology. Aug2024, Vol. 113 Issue 2, p257-259. 3p. |
| Subject Terms: |
*ANTIPSYCHOTIC agents, *DRUG side effects |
| Abstract: |
This article discusses the association between second-generation antipsychotic medications and the risk of venous thromboembolism (VTE). The study analyzed data from the FDA Adverse Event Reporting System (FAERS) and found that olanzapine and quetiapine were disproportionately associated with an increased rate of VTE and pulmonary embolism (PE). However, it is unclear if the increased risk is due to the antipsychotics themselves or underlying risk factors. The study suggests that further research is needed to understand the differences among antipsychotics in relation to VTE risk and their potential mechanisms of action. [Extracted from the article] |
|
Copyright of European Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
